Conditions for the implementation of intervention to reduce hepatitis C virus infection among drug users - qualitative study results

被引:0
作者
Dabrowska, Katarzyna [1 ]
Sieroslawski, Janusz [1 ]
机构
[1] Inst Psychiat & Neurol, Zaklad Badan Alkoholizmem & Toksykomaniami, Ul Sobieskiego 9, PL-02957 Warsaw, Poland
来源
ALKOHOLIZM I NARKOMANIA-ALCOHOLISM AND DRUG ADDICTION | 2015年 / 28卷 / 04期
关键词
Risk factors; HCV infection; Drug use; Prevention;
D O I
10.1016/j.alkona.2015.11.001
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Introduction: Drug users are particularly exposed to the risk of HCV infection. At the same time, this is a difficult group to reach out with preventive measures. The aim of the study was recognition of respondents' needs for intervention to reduce hepatitis C virus infection, including the identification of preferences on the conditions of its implementation and execution. Method: Results are based on outcomes of 25 group interviews with drug users and professionals and 20 individual interviews with drug users. Analysis included systemic investigation to create the frame of analysis based on codes, which emerged from the material. In the second stage of analysis, selective coding was used to combine a priori categories drawn from research interests. Results: Respondents expressed their suggestions regarding the character of the planned intervention and the conditions for its implementation. They turned attention to the potential barriers that may hinder the use of preventive measures. Physical accessibility, providing a sense of security and anonymity, duration and nature of the intervention adjusted to conditions of implementation and repeatability and complexity of activities are key elements that can affect the success of the intervention. Discussion: So far, HCV was not sufficiently present in the preventive interventions addressed to drug users. There is a need to develop comprehensive, long-term preventive strategy that on the one hand will provide the necessary knowledge, and on the other, change drug users' attitudes to becoming more health oriented. Conclusions: The planned intervention should take into account the needs of HCV infected and non-infected drug users. The activities should be carried out cyclically. (C) 2015 Institute of Psychiatry and Neurology. Production and hosting by Elsevier Sp. z o. o.
引用
收藏
页码:199 / 212
页数:14
相关论文
共 40 条
[1]  
Babbie E, 2006, BADANIA SPOLECZNE PR
[2]   Exploring the contingent reality of biomedicine: Injecting drug users, hepatitis C virus and risk [J].
Carrier, N ;
Laplante, J ;
Bruneau, J .
HEALTH RISK & SOCIETY, 2005, 7 (02) :123-140
[3]  
CHAMOT E, 1992, AIDS, V6, P430, DOI 10.1097/00002030-199204000-00013
[4]   Prevalence and risk factors for HIV among sniffers, short-term injectors, and long-term injectors of heroin [J].
Chitwood, DD ;
Comerford, M ;
Sanchez, J .
JOURNAL OF PSYCHOACTIVE DRUGS, 2003, 35 (04) :445-453
[5]   Methadone maintenance and hepatitis C virus infection among injecting drug users [J].
Crofts, N ;
Nigro, L ;
Oman, K ;
Stevenson, E ;
Sherman, J .
ADDICTION, 1997, 92 (08) :999-1005
[6]  
Davis M., 2004, International Journal of Drug Policy, V15, P123, DOI 10.1016/j.drugpo.2003.10.009
[7]   Can intranasal drug use reduce HCV infection among injecting drug users? [J].
Des Jarlais, Don C. ;
Hagan, Holly ;
Arasteh, Kamyar ;
McKnight, Courtney ;
Semaan, Salaam ;
Perlman, David C. .
DRUG AND ALCOHOL DEPENDENCE, 2011, 119 (03) :201-206
[8]   'There is no profile it is just everyone': The challenge of targeting hepatitis C education and prevention messages to the diversity of current and future injecting drug users [J].
Ellard, Jeanne .
INTERNATIONAL JOURNAL OF DRUG POLICY, 2007, 18 (03) :225-234
[9]   Prevalence of Hepatitis B Virus and Risk Factors in Brazilian Non-Injecting Drug Users [J].
Ferreira, Renata C. ;
Rodrigues, Fabiana P. ;
Teles, Sheila A. ;
Lopes, Carmen L. R. ;
Motta-Castro, Ana Rita C. ;
Novais, Antonia C. M. ;
Souto, Francisco J. D. ;
Martins, Regina M. B. .
JOURNAL OF MEDICAL VIROLOGY, 2009, 81 (04) :602-609
[10]  
Gilchrists G, 2013, OGRANICZANIE RYZYKOW